CLINICAL TRIAL

Treatment for Myofascial Pain Syndromes

EnrollingByInvitation · 18+ · All Sexes · Tucson, AZ

This study is evaluating whether a set of activities can improve pain in people with chronic pain.

See full description

About the trial for Myofascial Pain Syndromes

Eligible Conditions
Myofascial Trigger Point Pain (MTrP) · Pain Syndrome Myofascial · Myofascial Pain Syndromes

Treatment Groups

This trial involves 3 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are in Phase 2 and have already been tested with other people.

Control Group 1
1% plain lidocaine and 0.25% plain bupivacaine
COMBINATIONPRODUCT
Control Group 2
1% plain lidocaine and 0.25% plain bupivacaine
COMBINATIONPRODUCT
Control Group 3
1% plain lidocaine and 0.25% plain bupivacaine
COMBINATIONPRODUCT

Eligibility

This trial is for patients born any sex aged 18 and older. There are 3 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
Able to speak, read and write English
Diagnosis of myofascial pain
Failed conservative therapy or unable to participate in physical therapy
View All
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: 60 days
Screening: ~3 weeks
Treatment: Varies
Reporting: 60 days
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: 60 days.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Treatment will improve 1 primary outcome and 2 secondary outcomes in patients with Myofascial Pain Syndromes. Measurement will happen over the course of 60 days.

Change in Sleep patterns
60 DAYS
Change the Pittsburgh Sleep Quality Assessment Questionnaire by at least 30 percent. The Pittsburgh Sleep Quality Assessment Questionnaire has a scale from 0-21. The lower the score, the better the sleep quality.
60 DAYS
Change in pain intensity
60 DAYS
The primary outcome is the length of time patients subjectively report at least 50 percent reduction in pain compared to their baseline following trigger point injections using the Numerical Pain Scale which ranges from 0-10, where 0 = no pain and 10 = the worst possible pain.
60 DAYS
Perceived Subjective Changes in the Ability to Work, Do Chores, and Exercise.
60 DAYS
Changes in abilities of the participants to work, do chores, and exercise by at least 30 percent. This will be assessed using subjective reports from the recruited participants. The participants will be asked to report their perceived changes in their ability to Work, do chores, and exercise. Zero percent indicates no change from baseline. one hundred percent indicates complete resolution of the perceived problem.
60 DAYS

Who is running the study

Principal Investigator
M. I.
Prof. Mohab Ibrahim, MD PhD
University of Arizona

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is myofascial pain syndromes?

Myofascial pain syndromes can be associated with trigger points, which are painless points where the fascia of the muscle are most painful. Patients who use massage and other relaxation therapies experience significantly greater pain relief than do those who do not.

Anonymous Patient Answer

How many people get myofascial pain syndromes a year in the United States?

Each year, around 19.9 million Americans develop a myofascial pain syndrome. It is likely that this disease is more common in older Americans, given that it has a more rapid onset.

Anonymous Patient Answer

What are the signs of myofascial pain syndromes?

Myofascial pain syndromes can present as acute exacerbations of chronic myofascial pain, tenderness, or taut bands. Additionally, we provide a list of general signs of acute myofascial pain syndrome.

Anonymous Patient Answer

What causes myofascial pain syndromes?

It is highly probable that in most cases of muscular pain and stiffness the main underlying physical cause is myofascial pathology. However, patients with certain neurological conditions may develop muscle tenderness as a manifestation of a central neuropathy.

Anonymous Patient Answer

Can myofascial pain syndromes be cured?

The current findings suggest there is no reliable method for the elimination of myofascial pain syndromes. However, in some cases, patients are able to control their symptoms when other causes of secondary myofascial pain syndromes are eliminated. Recent findings are consistent with the hypothesis that these disorders are, in part, related to a non-specific somatic pain network.

Anonymous Patient Answer

What are common treatments for myofascial pain syndromes?

Myofascial pain syndromes often respond to conservative treatment. Exercise can be utilized to strengthen muscles and prevent the progression of disability. When conservative treatment fails, surgical myofascial release may improve symptoms and functionality.

Anonymous Patient Answer

How serious can myofascial pain syndromes be?

Although MFSs occur most frequently in young healthy adults, we found that MPS was more serious. Although many people with MFSs have high levels of symptoms, the long-term impact of those with severe symptoms is unknown.

Anonymous Patient Answer

What is treatment?

There is strong evidence for multiple treatment modalities for M. myofasciatum. Pain and swelling decrease significantly after multiple treatments including topical cicatrical agents (e.g., lidocaine, xylocaine, benzolycin) and/or oral analgesics, preferably in the form of nonsteroidal anti-inflammatory drugs. However, no single treatment modality can be recommended without giving consideration to the severity of the muscle damage and the other treatments. The pain often persists due to poor analgesic and/or anti-inflammatory response and patients should be encouraged to use additional treatments to make a more significant pain relief available in this scenario.

Anonymous Patient Answer

What is the latest research for myofascial pain syndromes?

This article provides the most recent research and articles about myofascial pain syndromes, which may be helpful to clinicians. Also, this article presents a review of literature from 2000-2016 regarding myofascial pain syndromes.

Anonymous Patient Answer

Is treatment safe for people?

The use of physiotherapy can be an effective and safe treatment for myofascial pain syndromes. No harm was identified, although there was a small decrease in pain severity when compared to a no-intervention control group.

Anonymous Patient Answer

What is the average age someone gets myofascial pain syndromes?

It is commonly perceived that patients experiencing myofascial pain syndromes develop myofascial pain syndromes as they get older. However, there are patients who develop myofascial pain syndromes at a younger age. More research is needed to investigate if myofascial pain syndromes are a natural process.

Anonymous Patient Answer

Is treatment typically used in combination with any other treatments?

A majority of respondents were satisfied with the quality of their treatment. Data from a recent study highlight that there is not a "one" treatment for FM. In the future, there may be a role for new treatment modalities.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for Myofascial Pain Syndromes by sharing your contact details with the study coordinator.